View Author

Godard, C. A.

(Claudine Godard)


mupirocin aureus patient bacteraemia mupirocin prophylaxis aureus bacteraemia haemodialysi incidence prophylaxi infection study patient-year haemodialysis patients carriage month staphylococcus 6 months dialysis carrier boelaert staphylococcus aureus period treatment mupirocin resistance study periods ointment calcium culture analysis episode staphylococcus aureus bacteraemia 106 patients staphylococcus aureus infections maintenance haemodialysis aureu ~ bacteraemia population maintenance trial resistance catheter development haemodialysis population 44.1 patient-years characteristic venous catheter eradication pre-mupirocin era mupirocin application haemodialysis unit result 43 patient-years aureu mupirocin use iron overload table i aureu ~ diabetes mellitus b 8000 bruges diabetes fisher blood uureus bacteraemia 4*26- application 6 months study hemodialysi haemodialysis patients increases follow-up pre-mupirocin baere haemodialysis 45 incidence contingency table analysis patients <65 years haemodialysis 43 results absence table aureus mupirocin bacteraemia aureus bacteraemia patient-year van landuyt hw bacteraemiasin haemodialysis patients mellitu




2 Most Recent Publications

Nasal Mupirocin Ointment Dicreases the Incidence of Staphylococcus Aureus Bacteraemias in Haemodialysis Patients (Article)
Boelaert, J.R. Landuyt, H.W. van Godard, C. A. Daneels, R.F. Schurgers, M.L. Matthys, E.G. Baere, Y.A. de Gheyle, D.W. Gordts, B.Z. Herwaldt, L.A.
1993-01-01
The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost- effectiveness (Article)
Boelaert, J.R. Geernaert, M. A. Godard, C. A. Landuyt, H.W. van Baere, Y.A. de
1991-01-01